Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE
Gregory D. Gregory, Shveta S. Raju, Susan Winandy, Melissa A. Brown
Gregory D. Gregory, Shveta S. Raju, Susan Winandy, Melissa A. Brown
View: Text | PDF
Research Article Immunology

Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE

  • Text
  • PDF
Abstract

When exposed to a pathogen, a naive CD4+ T cell is forced to make a cell fate decision that leads to a polarized population of Th1 IFN-γ– or Th2 IL-4– producing cells. Although IL-4 has traditionally been considered a factor that promotes Th2 cell differentiation, recent evidence has demonstrated that the site and timing of IL-4 expression in an immune response determines its ultimate effects on CD4+ T cell fate. Using a mast cell (MC) reconstitution model, we demonstrate that MC-derived IL-4 promoted Th1 responses in vivo. Furthermore, MCs from genetically disparate mouse strains varied in their potential for IL-4 expression. Independent of the activation mode, MCs from Th1-prone C57BL/6 mice exhibited a more robust Il4 response than did the Th2-prone strain Balb/c. The hierarchy of IL-4 expression potential was directly associated with the degree of basal chromatin accessibility at cis-regulatory elements conserved noncoding sequence–1 and VA enhancer within the Th2 locus. GATA1/2 and Ikaros, factors with opposing roles in chromatin remodeling, acted at these sites. We propose that GATA and Ikaros proteins coordinately fine-tune accessibility at the Il4 locus during development to variably regulate IL-4 expression. These events likely contribute to the genetically determined heterogeneity in Th1 responses that underlie susceptibility to many diseases.

Authors

Gregory D. Gregory, Shveta S. Raju, Susan Winandy, Melissa A. Brown

×

Figure 2

MCs exhibit strain-specific differences in Il4 expression after FcεRI cross-linking.

Options: View larger image (or click on image) Download as PowerPoint
MCs exhibit strain-specific differences in Il4 expression after FcεRI cr...
(A) Surface expression of FcεRI and c-kit on BMMCs from B6, Balb/c, and SJL mice after 6–8 weeks of culture in IL-3 and SCF. The mean fluorescent intensity of both c-kit and FcεRI is essentially equivalent in all strains. Iso, isotype. (B and C) Kinetics of BMMC cytokine mRNA expression after FcεRI cross-linking. Ribonuclease protection assays were performed to measure cytokine transcripts from B6, Balb/c, and SJL MCs at resting state (0 hours) and at various times after stimulation by FcεRI cross-linking. Ribonuclease protection assays were visualized by autoradiography after 16 hours (Il5, Il6, Il13, and Gapdh) or 5 days (Il4) and quantified by phosphorimaging (n = 2–4 per time point). mRNA levels were expressed relative to the housekeeping gene GAPDH and calculated as (cytokine intensity/GAPDH intensity) × 100. *P < 0.05; **P < 0.01 (ANOVA followed by Bonferroni’s multiple comparison test). (D) Freshly isolated naive CD4+ T cells from B6, Balb/c, and SJL mice were cultured under Th2 skewing conditions for 7 days and restimulated with plate-bound anti-TCRβ. Il4 expression was measured and quantified as in C. Two independent experiments were performed. stim, stimulation.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts